Prelude Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.06M Sell
29,267
-870
-3% -$210K 0.69% 20
2025
Q1
$7.34M Buy
30,137
+22,029
+272% +$5.37M 0.56% 15
2024
Q4
$2.66M Sell
8,108
-1,117
-12% -$367K 0.17% 103
2024
Q3
$3.09M Sell
9,225
-12,800
-58% -$4.28M 0.19% 109
2024
Q2
$6.02M Sell
22,025
-31,498
-59% -$8.6M 0.42% 33
2024
Q1
$18.5M Buy
53,523
+3,974
+8% +$1.37M 0.97% 3
2023
Q4
$16M Buy
49,549
+8,794
+22% +$2.84M 1.06% 4
2023
Q3
$14.6M Buy
40,755
+16,762
+70% +$6.01M 0.95% 8
2023
Q2
$9.1M Buy
23,993
+9,477
+65% +$3.59M 0.59% 16
2023
Q1
$6.95M Buy
14,516
+486
+3% +$233K 0.42% 29
2022
Q4
$5.9M Buy
14,030
+9,830
+234% +$4.13M 0.31% 54
2022
Q3
$1.75M Buy
4,200
+786
+23% +$328K 0.06% 260
2022
Q2
$1.69M Buy
+3,414
New +$1.69M 0.05% 283
2021
Q2
Sell
-529
Closed -$302K 1369
2021
Q1
$302K Buy
+529
New +$302K 0.01% 786
2020
Q3
Sell
-176
Closed -$79K 1393
2020
Q2
$79K Buy
176
+13
+8% +$5.84K ﹤0.01% 707
2020
Q1
$57K Sell
163
-243
-60% -$85K ﹤0.01% 454
2019
Q4
$150K Buy
+406
New +$150K 0.01% 605
2019
Q1
Sell
-1,040
Closed -$242K 1360
2018
Q4
$242K Buy
1,040
+816
+364% +$190K 0.02% 456
2018
Q3
$70K Sell
224
-2,829
-93% -$884K ﹤0.01% 750
2018
Q2
$881K Buy
3,053
+670
+28% +$193K 0.06% 271
2018
Q1
$596K Sell
2,383
-4,839
-67% -$1.21M 0.04% 345
2017
Q4
$1.72M Sell
7,222
-3,113
-30% -$743K 0.14% 128
2017
Q3
$2.3M Sell
10,335
-561
-5% -$125K 0.21% 96
2017
Q2
$2.47M Buy
10,896
+288
+3% +$65.2K 0.23% 85
2017
Q1
$2.12M Buy
10,608
+3,421
+48% +$682K 0.2% 109
2016
Q4
$1.31M Sell
7,187
-3,665
-34% -$668K 0.16% 154
2016
Q3
$1.78M Buy
10,852
+10,628
+4,745% +$1.74M 0.19% 113
2016
Q2
$32K Sell
224
-263
-54% -$37.6K ﹤0.01% 1094
2016
Q1
$67K Buy
+487
New +$67K 0.01% 811
2015
Q2
Sell
-526
Closed -$71K 1607
2015
Q1
$71K Buy
+526
New +$71K 0.01% 1110
2014
Q3
Sell
-391
Closed -$47K 1743
2014
Q2
$47K Buy
391
+181
+86% +$21.8K 0.01% 1230
2014
Q1
$27K Sell
210
-20
-9% -$2.57K ﹤0.01% 1435
2013
Q4
$28K Buy
230
+70
+44% +$8.52K ﹤0.01% 1186
2013
Q3
$19K Buy
+160
New +$19K ﹤0.01% 1097